DR Matthews, BH Charbonnel, M Hanefeld, P … - Diabetes/Metabolism … - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets. In
this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the ... Cited by 89 - Related articles - All 3 versions
J Jager, A Kooy, PH Lehert, D Bets, MG … - Journal of internal …, 2005 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets. In
this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the ... Cited by 84 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org J Martin, ZQ Wang, XH Zhang, D Wachtel, J … - Diabetes Care, 2006 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Thirty-seven subjects with type 2 diabetes were evaluated. After
baseline, subjects were placed on a sulfonylurea (glipizide gastrointestinal therapeutic system 5
mg/day) with placebo for 3 months. ... Cited by 50 - Related articles - BL Direct - All 9 versions
SM Setter, JL Iltz, J Thams, RK Campbell - Clinical therapeutics, 2003 - Elsevier Results: Metformin is the only currently available oral antidiabetic/hypoglycemic agent that acts
predominantly by inhibiting hepatic glucose release. Because patients with type 2 diabetes often
have excess hepatic glucose output, ... Cited by 49 - Related articles - All 3 versions
BE Sobel, DJ Taatjes, DJ Schneider… - … Thrombosis and Vascular …, 2003 - Am Heart Assoc Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone: 410-528-4050. Permissions:
Permissions & Rights Desk, Lippincott Williams & Wilkins, a division of Wolters ... Burton E.
Sobel, Douglas J. Taatjes, David J. ... Cited by 49 - Related articles - BL Direct - All 7 versions
BE Sobel, DJ Schneider - Cardiology clinics, 2004 - Elsevier Several interdigitating systems determine an overall predilection toward coagulation in vivo. Among
them is the coagulation cascade itself. It comprises two linked pathways through which activated
coagulation factor X can be ... Cited by 24 - Related articles - BL Direct - All 3 versions
DSH Bell - Clinical therapeutics, 2004 - Elsevier A comprehensive search of the MEDLINE and PubMed databases for the years 1966 to present anda
thorough review of abstracts of recently presented clinical trials were used to identify relevant
literature on dosing conversion and ... Cited by 25 - Related articles - All 4 versions
IW Campbell - International journal of clinical practice, 2004 - interscience.wiley.com Patients with type 2 diabetes have dual defects: insulin resistance and β-cell dysfunction.
Thiazolidinediones (TZDs), a new class of oral drugs used for the treatment of type 2 diabetes,
reduce insulin resistance via an ... Cited by 19 - Related articles - BL Direct - All 5 versions
BE Sobel - Front Biosci, 2003 - bioscience.org Diabetes is characterized by impaired fibrinolysis. This phenomenon reflects augmented
concentrations of plasminogen activator inhibitor type-1 in tissues and in blood. The derangement
appears to depend in part on ... Cited by 14 - Related articles - View as HTML - All 2 versions
M Feinglos, G Dailey, W Cefalu, K Osei, J Tayek, W … - Diabetes research and …, 2005 - Elsevier The addition of glipizide GITS to metformin gave significantly greater improvements in mean A 1c and
FPG from baseline to endpoint than placebo addition (p < 0.0002). Significantly more patients in the
glipizide GITS group than in the ... Cited by 13 - Related articles - All 8 versions
